Liquid Biopsy For Cancer Diagnostics Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global liquid biopsy for cancer diagnostics market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for liquid biopsy for cancer diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The liquid biopsy for cancer diagnostics market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider liquid biopsy for cancer diagnostics market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by cancer, by sample and by end user.
- Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the liquid biopsy for cancer diagnostics market.
- Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis -Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
- Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by cancer, by end user and by sample in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
- Regional Market Size And Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for liquid biopsy for cancer diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
1) By Type: Product; Services
2) By Cancer: Lung Cancer; Breast Cancer; Colon Cancer; Other Cancers
3)By Sample: Blood; Urine; Saliva
4) By End User: Hospitals; Diagnostic Centers; Other End Users
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Guardant Health Inc.; Illumina Inc.; Exact Sciences Corporation
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; liquid biopsy for cancer diagnostics indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- 1 Executive Summary
- 1.1 Liquid Biopsy For Cancer Diagnostics – Market Attractiveness And Macro Economic Landscape
- 2 Table Of Contents
- 3 List Of Tables
- 4 List Of Figures
- 5 Report Structure
- 6 Market Characteristics
- 6.1 General Market Definition
- 6.2 Summary
- 6.3 Liquid Biopsy For Cancer Diagnostics Market Definition And Segmentations
- 6.4 Market Segmentation By Type
- 6.4.1 Product
- 6.4.2 Services
- 6.5 Market Segmentation By Cancer
- 6.5.1 Lung Cancer
- 6.5.2 Breast Cancer
- 6.5.3 Colon Cancer
- 6.5.4 Other Cancers
- 6.6 Market Segmentation By Sample
- 6.6.1 Blood
- 6.6.2 Urine
- 6.6.3 Saliva
- 6.7 Market Segmentation By End User
- 6.7.1 Hospitals
- 6.7.2 Diagnostic Centers
- 6.7.3 Other End Users
- 7 Major Market Trends
- 7.1 High-Precision Liquid Biopsy For Identifying Cancer Biomarkers
- 7.2 Advancements In Automated Liquid Biopsy Technologies For Oncology And Prenatal Care
- 7.3 Next-Generation Liquid Biopsy Tool Improves Cancer Screening Capabilities
- 7.4 Technological Advancement In Liquid Biopsy For Personalized Cancer Treatment
- 7.5 Enhancing Tumor Detection And Profiling With Liquid Biopsy
- 8 Liquid Biopsy For Cancer Diagnostics Market – Macro-Economic Scenario
- 8.1 COVID-19 Impact On The Liquid Biopsy For Cancer Diagnostics Market
- 8.2 Impact Of The War In Ukraine On The Liquid Biopsy For Cancer Diagnostics Market
- 8.3 Impact Of High Inflation On The Liquid Biopsy For Cancer Diagnostics Market
- 9 Global Market Size and Growth
- 9.1 Market Size
- 9.2 Historic Market Growth, 2019 – 2024, Value ($ Million)
- 9.2.1 Market Drivers 2019 – 2024
- 9.2.2 Market Restraints 2019– 2024
- 9.3 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)
- 9.3.1 Market Drivers 2024 – 2029
- 9.3.2 Market Restraints 2024 – 2029
- 10 Global Liquid Biopsy For Cancer Diagnostics Market Segmentation
- 10.1 Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 10.2 Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 10.3 Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 10.4 Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 11 Liquid Biopsy For Cancer Diagnostics Market, Regional and Country Analysis
- 11.1 Global Liquid Biopsy For Cancer Diagnostics Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 11.2 Global Liquid Biopsy For Cancer Diagnostics Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12 Asia-Pacific Market
- 12.1 Summary
- 12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate Tax Structure
- 12.2.10 Investments
- 12.2.11 Major Companies
- 12.3 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.4 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.5 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.6 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market: Country Analysis
- 12.7 China Market
- 12.8 Summary
- 12.9 Market Overview
- 12.9.1 Country Information
- 12.9.2 Market Information
- 12.9.3 Background Information
- 12.9.4 Government Initiatives
- 12.9.5 Regulations
- 12.9.6 Regulatory Bodies
- 12.9.7 Major Associations
- 12.9.8 Taxes Levied
- 12.9.9 Corporate Tax Structure
- 12.9.10 Investments
- 12.9.11 Major Companies
- 12.10 China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.11 China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.12 China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.13 India Market
- 12.14 India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.15 India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.16 India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.17 Japan Market
- 12.18 Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.19 Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.20 Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.21 Australia Market
- 12.22 Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.23 Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.24 Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.25 Indonesia Market
- 12.26 Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.27 Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.28 Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.29 South Korea Market
- 12.30 South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.31 South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 12.32 South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13 Western Europe Market
- 13.1 Summary
- 13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate tax structure
- 13.2.10 Investments
- 13.2.11 Major Companies
- 13.3 Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.4 Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.5 Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.6 Western Europe Liquid Biopsy For Cancer Diagnostics Market: Country Analysis
- 13.7 UK Market
- 13.8 UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.9 UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.10 UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.11 Germany Market
- 13.12 Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.13 Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.14 Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.15 France Market
- 13.16 France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.17 France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.18 France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.19 Italy Market
- 13.20 Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.21 Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.22 Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.23 Spain Market
- 13.24 Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.25 Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 13.26 Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 14 Eastern Europe Market
- 14.1 Summary
- 14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Major companies
- 14.3 Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 14.4 Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 14.5 Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 14.6 Eastern Europe Liquid Biopsy For Cancer Diagnostics Market: Country Analysis
- 14.7 Russia Market
- 14.8 Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 14.9 Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 14.10 Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 15 North America Market
- 15.1 Summary
- 15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Investments
- 15.2.11 Major Companies
- 15.3 North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 15.4 North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 15.5 North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 15.6 North America Liquid Biopsy For Cancer Diagnostics Market: Country Analysis
- 15.7 USA Market
- 15.8 Summary
- 15.9 Market Overview
- 15.9.1 Country Information
- 15.9.2 Market Information
- 15.9.3 Background Information
- 15.9.4 Government Initiatives
- 15.9.5 Regulations
- 15.9.6 Regulatory Bodies
- 15.9.7 Major Associations
- 15.9.8 Taxes Levied
- 15.9.9 Corporate Tax Structure
- 15.9.10 Investments
- 15.9.11 Major Companies
- 15.10 USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 15.11 USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 15.12 USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 15.13 Canada Market
- 15.14 Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 15.15 Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 15.16 Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 16 South America Market
- 16.1 Summary
- 16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Major Companies
- 16.3 South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 16.4 South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 16.5 South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 16.6 South America Liquid Biopsy For Cancer Diagnostics Market: Country Analysis
- 16.7 Brazil Market
- 16.8 Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 16.9 Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 16.10 Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 17 Middle East Market
- 17.1 Summary
- 17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Major Companies
- 17.3 Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 17.4 Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 17.5 Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 18 Africa Market
- 18.1 Summary
- 18.2 Market Overview
- 18.2.1 Region Information
- 18.2.2 Market Information
- 18.2.3 Background Information
- 18.2.4 Government Initiatives
- 18.2.5 Regulations
- 18.2.6 Regulatory Bodies
- 18.2.7 Major Associations
- 18.2.8 Taxes Levied
- 18.2.9 Corporate Tax Structure
- 18.2.10 Major Companies
- 18.3 Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 18.4 Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 18.5 Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
- 19 Competitive Landscape And Company Profiles
- 19.1 Company Profiles
- 19.2 F. Hoffman-La Roche Ltd
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial Overview
- 19.3 Thermo Fisher Scientific Inc
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Business Strategy
- 19.3.4 Financial Overview
- 19.4 Guardant Health Inc
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial Overview
- 19.5 Illumina Inc.
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Financial Overview
- 19.6 Exact Sciences Corporation
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Business Strategy
- 19.6.4 Financial Overview
- 20 Other Major And Innovative Companies
- 20.1 Natera Inc.
- 20.1.1 Company Overview
- 20.1.2 Products And Services
- 20.2 Johnson & Johnson Services Inc.
- 20.2.1 Company Overview
- 20.2.2 Products And Services
- 20.3 Bio-Rad Laboratories Inc.
- 20.3.1 Company Overview
- 20.3.2 Products And Services
- 20.4 Caris Life Science
- 20.4.1 Company Overview
- 20.4.2 Products And Services
- 20.5 Sysmex Corporation
- 20.5.1 Company Overview
- 20.5.2 Products And Services
- 20.6 Qiagen NV
- 20.6.1 Company Overview
- 20.6.2 Products And Services
- 20.7 Myriad Genetic Laboratories Inc.
- 20.7.1 Company Overview
- 20.7.2 Products And Services
- 20.8 Invitae Corporation
- 20.8.1 Company Overview
- 20.8.2 Products And Services
- 20.9 Freenome Holdings Inc.
- 20.9.1 Company Overview
- 20.9.2 Products And Services
- 20.1 Tempus Labs, Inc.
- 20.10.1 Company Overview
- 20.10.2 Products And Services
- 20.11 MDxHealth SA
- 20.11.1 Company Overview
- 20.11.2 Products And Services
- 20.12 NeoGenomics Laboratories Inc.
- 20.12.1 Company Overview
- 20.12.2 Products And Services
- 20.13 ExosomeDx
- 20.13.1 Company Overview
- 20.13.2 Products And Services
- 20.14 Biodesix Inc.
- 20.14.1 Company Overview
- 20.14.2 Products And Services
- 20.15 Biocartis Group NV.
- 20.15.1 Company Overview
- 20.15.2 Products And Services
- 21 Competitive Benchmarking
- 22 Competitive Dashboard
- 23 Key Mergers And Acquisitions
- 23.1 Quest Diagnostics Acquired Haystack Oncology
- 23.2 Exact Sciences Corporation Acquired Resolution Bioscience, Inc.
- 23.3 Exact Sciences Corporation Acquired Thrive Earlier Detection
- 24 Opportunities And Strategies
- 24.1 Global Liquid Biopsy For Cancer Diagnostics Market In 2029 – Countries Offering Most New Opportunities
- 24.2 Global Liquid Biopsy For Cancer Diagnostics Market In 2029 – Segments Offering Most New Opportunities
- 24.3 Global Liquid Biopsy For Cancer Diagnostics Market In 2029 – Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies
- 25 Liquid Biopsy For Cancer Diagnostics Market, Conclusions And Recommendations
- 25.1 Conclusions
- 25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People
- 26 Appendix
- 26.1 Geographies Covered
- 26.2 Market Data Sources
- 26.3 Research Methodology
- 26.4 Currencies
- 26.5 The Business Research Company
- 26.6 Copyright and Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook